ロード中...
Statins: Can we advocate them for primary prevention of heart disease?
The discovery of cholesterol-lowering agents, namely HMG-CoA reductase inhibitors or statins, ushered in a series of large cholesterol reduction trials. The first of these studies was the Scandinavian Simvastatin Survival Study (4S) in which hypercholesterolemic men with CHD who were treated with si...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4213925/ https://ncbi.nlm.nih.gov/pubmed/25378782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2013.05.008 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|